Print Page   |   Sign In   |   Register
Newsletters
Blog Home All Blogs
Search all posts for:   

 

View all (109) posts »
 

Stock Market Manager Weekly Update: August 6th, 2018

Posted By Administration, Friday, August 10, 2018

SMM Logo

               

 

 

 

 Weekly Update: August 6th, 2018

 

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105401.png

http://ecomallymail.com/uploads/1524105419.png

6,462

1,414

472

131

6

 

 

Latest Happenings

Tesla- TSLA  $346.80

Great Update from ValuEngine 8-8-18

We have been tracking Tesla for a while here. As long-time readers know, we are definitely on the side of the shorts. Our models typically rate this stock a SELL, and despite the high share prices and the long-term trend, we cannot shake the feeling that something is wrong here.

Tesla, despite the massive valuation, has NEVER made a profit–and it most certainly isn’t Amazon, so that argument doesn’t fly with us. We believe Elon Musk benefits from a level of “fanboy” worship we haven’t seen since Steve Jobs died. We believe that all other Musk-linked activities–hyper loops, battery projects and rocket launches, serve as little more than PR to justify the share price of Tesla and hype the stock.

However–to paraphrase a wise trader, when you’re short you can definitely go broke even if you’re right. And so far, the shorts here have taken a bath. Musk seems to take their bets as a personal affront, and recent events show he may be taking actions to make their positions as expensive as possible.

complete report here

 

Breaking News

Consilium Global Research Issues Quarterly Update 8-7-18
Price Target $7.00 
>> For Quarterly Update >> Read MoreZynex is the leading provider of Electrotherapy Medical Devices used for pain management and rehabilitation. The company is also pioneering development of an Innovative Blood Volume Monitor.

Catalysts/Keys:

1. ZYXI reported 2Q18 EPS of $0.07 on revenue of $7.6 million, in-line with our forecast of $0.08 on revenue of $7.8 million. This compares to 2Q17 revenue of $5.0 million on EPS of $0.05. The growth on the top-line this quarter is up 50% over 2Q17 versus 53% growth Y/Y in 2Q17 over 2Q16. We are glad to see that the growth in the business continues.

2. Management took this opportunity to provide guidance for 3Q18E. Management expects revenue in the range of $7.7 - $8.2 million, EBITDA in the range of $2.8 - $3.2 million and EPS of $0.08. We would like to reiterate what we said last quarter, this type of granularity/predictability is certainly impressive, as it is unusual for a company of this size. We believe this speaks volumes about management’s ability.

3. As a result of this quarter’s performance, management’s guidance and our follow-up conversations with management we are making modest tweaks to our model. For 2018E we are now forecasting revenue of $31.1 million ($31.9 million previously) and EPS of $0.28 ($0.31 previously). For 2019E we are now revenue of $43.6 million ($44.6 million previously) and EPS of $0.40 ($0.41 previously). Making modest adjustments to our EBITDA forecasts, we now look for $10.2 million in 2018E down from $11.7 million and $12.8 million in 2019E, down from $15.8 million. Conclusion Our investment thesis is intact and we are glad to see that the on-going paradigm shift at ZYXI is proving beneficial to investors. As a result of our new foreacsts we our leaving our fair value estimate of $7 unchanged, which assumes ZYXI can achieve an EV/EBITDA of 19.1x (15.8x previously), 17.6x P/E (17.1x previously) and EV/Sales of 5.6x (unchanged). Given the increased predictability/stability of the financials, we believe the modest change to the target multiples is appropriate.

Conclusion Our investment thesis is intact and we are glad to see that the on-going paradigm shift at ZYXI is proving beneficial to investors. As a result of our new foreacsts we our leaving our fair value estimate of $7 unchanged, which assumes ZYXI can achieve an EV/EBITDA of 19.1x (15.8x previously), 17.6x P/E (17.1x previously) and EV/Sales of 5.6x (unchanged). Given the increased predictability/stability of the financials, we believe the modest change to the target multiples is appropriate.

 

8-1-18 Trickle Research Issues Research Note
Social Reality, Inc.  
12-24 Month Price Target $7.50

Click Here for Research Note

While we recognize SRAX will report 2Q results over the next several days so we will likely have to address those as well, we wanted to provide a short view of the Company’s recent transaction involving the sale of SRAXmd. As most of you are probably aware, this is a transaction we have been anticipating and we have essentially pegged much of our valuation thesis around this asset. Here is a brief summary from the Company’s release regarding the metrics: On July 29, 2018 management signed an asset purchase agreement to sell all of the assets of the SRAXmd product line to an affiliate of private equity firm Halyard Capital for total consideration of up to $52.5 million. SRAX will receive $33.5 million in cash, $10 million in Class A membership units of Halyard MD, LLC, the parent of the entity acquiring the assets, and an earn-out of up to $9 million upon the buyer achieving certain gross profit thresholds by December 31, 2018. The transaction is expected to close on or about August 7, 2018, subject to customary closing conditions. We think the transaction validates something we have been saying for some time now which is/was that SRAXmd was/is likely worth more than the entire market cap of SRAX at those given points of reference. Granted, the $52.5 million purchase price has some caveats, one of which is that they essentially retained a portion of the deal by receiving shares of the buyer’s parent (we actually like that nuance) and, $9 million of it is contingent upon the performance of SRAXmd through the balance of 2018. We don’t know what those thresholds are so we don’t know if they are likely or unlikely, although we suspect they are within the realm of doable or they wouldn’t be part of the deal. That said, we submit, this could certainly end up being a $43.5 million deal rather than a $52.5 million deal, but in either case, we think it leads to the same question which is, what is the rest of SRAX worth? Clearly, with the with the market cap at about $45 million (as we write this), the market seems to be answering that question with “not much”.

 

Aug-6-18

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

     

Premium

Research

News

(listing, quotes, news, research)

     

Profile

Updates

Updates

Aethlon Medical, Inc. (AEMD)

 

Profile

   

Assure Holdings, Inc. (ARHH)

   

5-29-18

News

Antibe Therapeutics, Inc (ATBPF)

 

 

 

News

AzuerRx Biopharma, Inc. (AZRX)

 

5-2-18

News

Camino Minerals Corp. (CAMZF)

 

4-6-18

News

Canbiola, Inc. (CANB)

     

News

Chineseinvestors.com, Inc. (CIIX)

Profile

 

News

Command Center , Inc. (CCNI)

   

5-15-18

News

Endurance Exploration Group, Ltd (EXPL)

 

     Profile

1-25-18

News

Ecom Products Group (EPGC)

     

News

FULLSHARE HOLDINGS LTD. (607) HK

 

7-5-18

News

Galaxy Gaming, Inc. (GLXZ)

 

     Profile

   

Guangdong Land Holdings Limited (124) HK

6-4-18

News

Magnegas, Inc. (MNGA)

     

News

MOBI724 Global Solutions, Inc. (MOBIF)

   

News

New Jersey Mining Company (NJMC)

 

   5-17-18

News

Petroshare Corp. (PRHR)

 

 

7-15-18

News

Social Reality, Inc. (SRAX)

   

4-12-18

News

Zynex, Inc. (ZYXI)

   

8-9-18

News

 

 

 

 

 

 

 

8-8-18

VALUATION WATCH: Overvalued stocks now make up 52.62% of our stocks assigned a valuation and 20.33% of those equities are calculated to be overvalued by 20% or more. Twelve sectors are calculated to be overvalued.  

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

Trickle Research and GVC Capital
Rocky Mountain Microcap Conference October 9, 2018.
BlackHawk, Colorado at Ameristar Resort

On October 9, 2018, we will be holding Rocky Mountain Microcap Conference III.  The Conference will be held at the Ameristar Casino Resort Spa in Blackhawk, Colorado.  The agenda will be limited to just 13 public microcap companies.  The companies will present on a single track and each will be allotted a 25-minute presentation slot.  We hope to attract approximately 65-75 microcap investors, institutions and bankers who are close associates, clients and/or Trickle Research subscribers. Our spring conference had around 80 investor attendees).  We believe we will once again assemble a group of highly relevant microcap centric attendees.

Read More

 

Dawson James Securities
Small Cap Growth Conference Oct 29-30
Wyndham Grand Hotel –Jupiter Florida

Full Day--Two Track Presentations from over 30 Companies in Healthcare/Technology & Consumer Sectors

Uplist “Bootcamp” for Invited Guests

Monday Evening Panel/Welcome Cocktails

Last Year’s event was attended by over 250 of our Institutional, Family Office and High Net Worth Clients

Click Here to Register
 

NIBA New York Conference July 16-17

Great turnout and lot of good presentations at NIBA last week. We’ll publish a list of presenting companies shortly.

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)       1,414

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                     (contacts)                         472

SMM Youtube Channel            (followers)                                6

SMM Instagram                      (followers)                        131         

Direct Email                                                                 345,000

Total                                                                             353,485

ABOUT US

 

 

 

This post has not been tagged.

Share |
Permalink | Comments (0)
 
Community Search
Sign In